Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.
Patel YT, Daryani VM, Patel P, Zhou D, Fangusaro J, Carlile DJ, Martin PD, Aarons L, Stewart CF. Patel YT, et al. Among authors: patel p. CPT Pharmacometrics Syst Pharmacol. 2017 May;6(5):305-314. doi: 10.1002/psp4.12175. Epub 2017 Mar 22. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28326681 Free PMC article. Clinical Trial.
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia.
Applegate TL, Causer LM, Gow I, Alternetti N, Anderson L, Borgnolo B, Cooney L, Cunningham P, Fernando M, Hengel B, Huang RL, Kayago K, King JM, Lew HJ, Martinello M, Milic M, Miller K, O'Connor S, Patel P, Phillips E, Rawlinson W, Sharma A, Shephard MDS, Tangey A, Smith K, Williams AL, Andrewartha K, Guy R, Matthews SJ. Applegate TL, et al. Among authors: patel p. Expert Rev Mol Diagn. 2024 Dec 24:1-14. doi: 10.1080/14737159.2024.2403091. Online ahead of print. Expert Rev Mol Diagn. 2024. PMID: 39719681 Review.
2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort.
Bailey C, Chandran M, Gale R, Narendran N, Talks J, McGoey H, Keshk Z, Morgan-Warren P, Allmeier H, Machewitz T, Patel PJ, Varma D. Bailey C, et al. Among authors: patel pj. Eye (Lond). 2024 Dec 24. doi: 10.1038/s41433-024-03550-y. Online ahead of print. Eye (Lond). 2024. PMID: 39719502
9,009 results